AzTrials
AzTrials

Primary InsomniaCEBATINCT03461666

Comparison of Efficacy of Behavioral Approaches for Treatment of Insomnia

A study testing Cognitive Behavior Therapy-Insomnia, Focus of Attention and Combined-CBT-I and FOA Group in people with Primary Insomnia, run by Pacific Institute of Medical Sciences at 2 sites in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

This study compares the efficacy of four different types (Cognitive Behavior Therapy for Insomnia (CBT-I); Focus of Attention (FOA); Combined CBT-I and FOA; and Sleep Hygiene (control group) for the treatment of insomnia. Read more about this study

Who is it for?
Ages 18 to 72 yearsHealthy volunteers can take part
Conditions the study is for
Primary Insomnia
What is being tested?
Cognitive Behavior Therapy-Insomnia, Focus of Attention and Combined-CBT-I and FOA Group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
160 participants
Where
2 sitesUnited States
Study dates
5 Sep 2018to 1 Jul 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 72 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Male and female outpatients who are 18 or older to 72 years. Insomnia Severity Index > or = 10
  • Meet diagnostic criteria for Insomnia Disorder per DSM-5 Willing and able to sign Informed consent form Not planning on moving away from the area for the subsequent 12 weeks.

Who cannot join

  • Participants who answer "yes" to any of the following will be excluded:
  • Females who are lactating or who are pregnant
  • Night shift workers, and individuals who nap 3 or more times per week over the preceding month
  • Consumption of caffeine beverages (i.e. tea, coffee, or cola) comprising usually more than 5 cups or glasses per day
  • Participation in another trial for insomnia
  • Persons unable to complete the study questionnaires and psychological tests
Show all 16Show fewer
  • Persons who are unable to participate for the entire duration of the study, or in the opinion of the investigators, are likely to be non-compliant with the obligations inherent in the trial participation
  • Persons self-describing with severe anxiety or severe depression (BDI score of 29 or higher) or severe anxiety (BAI score of 36 or higher).
  • Persons with a history of epilepsy, seizures, or dementia
  • Any significant, severe or unstable, acute or chronically progressive medical or surgical condition
  • Serious head injury or stroke within the past year
  • Current alcohol or substance abuse/dependence (must have >90 days of sobriety)
  • Presence of other neurological disorders (e.g., multiple sclerosis, Parkinson's Disease)
  • Presence of an untreated or unstable medical or psychiatric comorbid condition (e.g., major depressive disorder or psychotic disorder requiring admission within the last two years). People using psychotropic medication, hypnotic or sedative medications may be included if they are on a stable dosage for the last 2 months prior to the study, if the dose remains stable throughout the study, and if the medication is judged to not interfere with the study outcomes.
  • Currently on medications known to produce insomnia (e.g., stimulants)
  • Sleep apnea (AHI >15) or previous diagnosis of sleep apnea. Study participants who use a continuous positive airway pressure (CPAP) device for sleep apnea will be eligible for participation if they are below the apnea/hypopnea cutoff while using CPAP and agree to use the device during study participation.

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Puget Sound Psychiatric Center

    Bothell, Washington, 98011

  • Puget Sound Psychiatry Center

    Bothell, Washington, 98011

Other trials in United States

About this study

Official title: A Randomized, Open Label, Sleep Hygiene Controlled 6-Week Study to Compare the Efficacy of Four (CBT-I, FOA, Combined CBT-I and FOA and Sleep Hygiene) Different Behavioral Approaches for the Treatment of Adult Subjects With Insomnia

This study compares the efficacy of four different types (Cognitive Behavior Therapy for Insomnia (CBT-I); Focus of Attention (FOA); Combined CBT-I and FOA; and Sleep Hygiene (control group) for the treatment of insomnia. This study is a randomized, open label study, and the participants are asked to assess the benefits they get from the intervention. This study involve 6 weekly in person one-to-one sessions after screening and completion of the 1-week, 3-month, 6-month and 12-month follow-up assessment. The trained study staff will administering the treatment. The Research Department will administer the outcome measures. The review of insomnia improvement will be assessed at at end of treatment, 3 months, 6 months and 12 months follow-up.

Read the detailed description

This study compares the efficacy of four different types (Cognitive Behavior Therapy for Insomnia (CBT-I), Focus of Attention (FOA), Combined CBT-I and FOA and Sleep Hygiene) of therapies approaches for the treatment of insomnia. This study is a randomized, open label study, the participants are asked to review the benefits they get from the intervention. This study involve 6 weekly sessions after screening and completion of the end of treatment, 3-month, 6-month and 12-month follow-up assessment. The trained study staff will administer study scales during therapy session. The subjective review of insomnia improvement will be assessed at end of treatment, 3 months, 6 months and 12 months follow-up assessment. Subjects are adult who meet, DSM-5 the diagnostic criteria for primary Insomnia.

Inclusion/Exclusion criteria to be assessed at Screening (Visit 1) and Visit 2. For those found eligible who complete the study, participation will include Screening (Visit 1), 6 weekly sessions after screening, and completion of the post-treatment and 6-month followup assessment.

Once subject sign the consent form, subject will be asked inclusion and exclusion criteria and will be given details about the study as per protocol.

Those eligible will be randomly assigned to one of four behavioral treatment approaches. The participant will have six weekly one hour in person sessions in which the assigned treatment will be administered. The participant will be assessed at the end of treatment and again at 6 month followup.

Being tested
Cognitive Behavior Therapy-Insomnia, Focus of Attention, Combined-CBT-I and FOA Group, Sleep Hygiene
Keywords
Primary insomnia, Behavioral treatment of primary insomnia, Focus of attention, cognitive behavioral therapy for insomnia
Medical subject headings
Sleep Initiation and Maintenance Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive Behavior Therapy-InsomniaBehavioural

    Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.

  • Focus of AttentionBehavioural

    Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.

  • Combined-CBT-I and FOA GroupBehavioural

    Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.

  • Sleep HygieneBehavioural

    Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.

Study groups in NCT03461666
Study groupRoleWhat they receive
Cognitive Behavior Therapy-InsomniaActive comparatorParticipants receive 6 one hour in person behavioral psycho-intervention sessions from a treatment provider.
Receives: Behavioral: Cognitive Behavior Therapy-Insomnia; Behavioral: Focus of Attention; Behavioral: Combined-CBT-I and FOA Group; Behavioral: Sleep Hygiene
Focus Of AttentionActive comparatorParticipants receive 6 one hour in person behavioral psycho-intervention sessions from a treatment provider.
Receives: Behavioral: Cognitive Behavior Therapy-Insomnia; Behavioral: Focus of Attention; Behavioral: Combined-CBT-I and FOA Group; Behavioral: Sleep Hygiene
Combined-CBT-I and FOA GroupActive comparatorParticipants receive 6 one hour in person behavioral psycho-intervention sessions from a treatment provider.
Receives: Behavioral: Cognitive Behavior Therapy-Insomnia; Behavioral: Focus of Attention; Behavioral: Combined-CBT-I and FOA Group; Behavioral: Sleep Hygiene
Sleep HygieneActive comparatorParticipants receive 6 one hour in person behavioral psycho-intervention sessions from a treatment provider.
Receives: Behavioral: Cognitive Behavior Therapy-Insomnia; Behavioral: Focus of Attention; Behavioral: Combined-CBT-I and FOA Group; Behavioral: Sleep Hygiene

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Self Report Sleep Measures

    SRSM: assess overall quantity of sleep satisfaction on the Self Report Sleep Measures.

    Measured: through study completion, an average of 1 year

Secondary outcomes (1)
  1. Insomnia Severity Index

    ISI: assess the severity of insomnia.

    Measured: through study completion, an average of 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Mar 2018
  2. Study start5 Sep 2018
  3. Primary completion1 Nov 2021
  4. Study completion1 Jul 2022

Why it stopped: Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention. COVID Complications.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
parallel group
Masking
None (open label)
Enrolment
160 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03461666
Sponsor's protocol ID
PSPC-17-01
Acronym
CEBATI
Status last verified
Mar 2023
First submitted
22 Dec 2017
Last updated
5 Apr 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Finding to present in peer review journals

Publications

  • Becher AK, Hohne M, Axmacher N, Chaieb L, Elger CE, Fell J. Intracranial electroencephalography power and phase synchronization changes during monaural and binaural beat stimulation. Eur J Neurosci. 2015 Jan;41(2):254-63. doi: 10.1111/ejn.12760. Epub 2014 Oct 25.

    PubMed 25345689
  • Cahn BR, Polich J. Meditation states and traits: EEG, ERP, and neuroimaging studies. Psychol Bull. 2006 Mar;132(2):180-211. doi: 10.1037/0033-2909.132.2.180.

    PubMed 16536641

Questions about this trial

What is this clinical trial studying?

A study testing Cognitive Behavior Therapy-Insomnia, Focus of Attention and Combined-CBT-I and FOA Group in people with Primary Insomnia, run by Pacific Institute of Medical Sciences at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 16 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 5 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention. COVID Complications.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Self Report Sleep Measures (time frame: through study completion, an average of 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03461666, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Apr 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in